• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home Posts by “Healthday News”
View Post

Workplace Sexual Harassment Tied to Suicide Risk

In HealthDay News
by Healthday
September 14, 2020

Association accounted for sociodemographic and work characteristics plus baseline health

View Post

Depression Worsens Over Time in Caregivers of Partners With Dementia

In HealthDay News
by Healthday
September 14, 2020

Symptoms sustained regardless of whether the diagnosis was less than or more than two years before

View Post

Study Examines Diet and Risk for Rheumatoid Arthritis in Women

In HealthDay News
by Healthday
September 14, 2020

Adherence to Mediterranean diet might lower rheumatoid arthritis risk in female ever-smokers

View Post

HPV Vaccination Rates Increasing Among 15-Year-Olds

In HealthDay News
by Healthday
September 14, 2020

Proportion of one- or two-dose HPV vaccination increased from 2011 to 2017; still falling short of goals

View Post

24.4 Percent of U.K. Health Care Workers Positive for SARS-CoV-2

In HealthDay News
by Healthday
September 14, 2020

Seroprevalence varies for health care workers in different departments; rate lower for ICU staff

View Post

Vaccine Confidence Recently Increased in Some of Europe

In HealthDay News
by Healthday
September 14, 2020

Confidence in importance, safety, effectiveness of vaccines down in Afghanistan, other countries

View Post

Among Hospital Patients, Children Less Likely to Carry SARS-CoV-2

In HealthDay News
by Healthday
September 14, 2020

Among those without COVID-19 symptoms, children less likely than adults to test positive for SARS-CoV-2

View Post

S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

In Atopic Dermatitis, Conditions, Eczema
by Healthday
July 28, 2020Leave a Comment

Expression of functional Agr system in S. aureus needed for epidermal colonization in mice. Skin colonization by Staphylococcus aureus is associated with the risk for developing atopic dermatitis (AD), and infants who do not …

View Post

Roflumilast Cream Promising for Chronic Plaque Psoriasis

In Conditions, HealthDay News Physician's Briefing, Psoriasis
by Healthday
July 15, 2020Leave a Comment

More patients in roflumilast groups have IGA score indicating status of clear or almost clear at week 6 Roflumilast cream is superior to placebo vehicle cream for reducing psoriasis severity, …

View Post

Nemolizumab Beats Placebo for Reduction of Pruritus in Eczema

In Atopic Dermatitis, Conditions, Eczema
by Healthday
July 9, 2020Leave a Comment

VAS score reduction greater at week 16 for addition of nemolizumab versus placebo to topical agents. For patients with atopic dermatitis and moderate-to-severe pruritus, nemolizumab results in a greater reduction …

  • Page 149 of 151
  • ←
  • 1
  • ...
  • 148
  • 149
  • 150
  • ...
  • 151
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Mar    

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer